Popular Eli Lilly weight-loss drug Zepbound can be covered by Medicare plans to treat sleep apnea after it received Food and ...

Obstructive sleep apnea is a condition that disrupts rest, leading to symptoms such as daytime fatigue, brain fog and headaches. In the long-term, untreated sleep apnea can have serious health ...

New research provides guidance on the effects of caffeine, diet and naps on sleep. Plus there are expanded treatments for ...

Sleep apnea involves repeated breathing interruptions during sleep, while loud snoring is steady and doesn’t typically affect breathing. A doctor can help confirm the difference. Sleep apnea is ...

Brett Bigelow, Provider Outreach, Sound Sleep, shows us an oral appliance that is used to treat obstructive sleep apnea and ...

Obstructive sleep apnea (OSA) is associated with an increased risk for cardiovascular disease (CVD) in adults, even those younger than 40 years, according to a study published online June 6 in the ...

A study reveals sleep apnea can cause brain damage, increasing risks of aging and dementia, particularly in Hispanic seniors.

Opens in a new tab or window The FDA approved tirzepatide (Zepbound) for adults with moderate-to-severe obstructive sleep apnea (OSA) and obesity, the agency announced late Friday. Used along with ...

It opens the door for broader coverage and access to Zepbound, which is not currently covered by Medicare and many other ...

Peer Support Could Help Millions With Sleep Apnea Slumber Easier, Study Says Dec. 4, 2024 — Continuous positive airway pressure, or CPAP, therapy can improve the lives of people with obstructive ...

Sleep apnea is known to wreak havoc with the body, contributing to heart problems, diabetes and liver disease. The sleep disorder also appears to have direct effects on brain health, a new study ...

The Food and Drug Administration approved Zepbound as the first prescription medicine to treat sleep apnea on Friday—marking a significant win for the drug company Eli Lilly, which had Zepbound ...